Effectiveness of Hyperbaric Oxygen Therapy in the Management of Osteoradionecrosis of the Jaw: A Systematic Review

Abstract

Osteoradionecrosis (ORN) of the jaws is the most dangerous long-term side effect of head and neck radiation therapy that can significantly affect the quality of life of the patients. In ORN of the jaw, the bone within the radiation field becomes devitalized and gets exposed via the overlying skin or mucosa, which remains unhealed. Hyperbaric oxygen therapy (HBOT) is used as an adjunctive therapy along with surgical debridement for the management of ORN of the jaws. HBOT promotes angiogenesis, neovascularization, fibroblast and osteoblast proliferation, and collagen production. However, the benefit of HBOT in improving the healing of tissues in patients with ORN remains controversial because of low evidence. The present systematic review aimed to compare the available data on the efficacy of HBOT on the healing of ORN of the jaw. Databases like PubMed, Scopus, Cochrane, Science Direct, Lilac, and Web of Science were searched without any date filter to obtain the relevant articles. A total of six articles met the eligibility criteria and were further processed for data extraction. Two retrospective studies observed that HBOT combined with surgical debridement promoted wound healing in patients with early stages of ORN of the jaws. Similarly, a prospective study reported that prophylactic HBOT reduced the risk of the development of ORN of the jaws following surgery to irradiated jaws. In contrast, three randomized controlled trials (RCTs) reported that HBOT did not improve the healing outcome of patients with advanced lesions of ORN of the jaws. Based on the scope of this review, we concluded that the routine use of HBOT for the prevention or management of ORN of the jaws is not recommended. Adjunctive HBOT may be considered in patients who have failed conservative therapy and subsequent surgical resection and are regarded to be at high risk.

Keywords

radiation therapy - osteoradionecrosis - mandible - hyperbaric oxygen therapy - wound healing

Publication History

Article published online:
12 July 2023

• References

• 1 Singh A, Huryn JM, Kronstadt KL, Yom SK, Randazzo JR, Estilo CL. Osteoradionecrosis of the jaw: a mini review. Front Oral Health 2022; 3: 980786
• 2 Sroussi HY, Epstein JB, Bensadoun RJ. et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 2017; 6 (12) 2918-2931
• 3 Suryawanshi AT, Santhosh Kumar SN, Dolas RS, Khindria R, Pawar V, Singh M. Maxillofacial osteoradionecrosis. Journal of Dental Research and Review. 2014; 1 (01) 42
• 4 Chronopoulos A, Zarra T, Ehrenfeld M, Otto S. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J 2018; 68 (01) 22-30
• 5 Lyons A, Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg 2008; 46 (08) 653-660
• 6 Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983; May; 41 (05) 283-288
• 7 Fan H, Kim SM, Cho YJ, Eo MY, Lee SK, Woo KM. New approach for the treatment of osteoradionecrosis with pentoxifylline and tocopherol. Biomater Res 2014; 18: 13
• 8 Ceponis P, Keilman C, Guerry C, Freiberger JJ. Hyperbaric oxygen therapy and osteonecrosis. Oral Dis 2017; 23 (02) 141-151
• 9 Ngeow WC, Tan CC, Goh YC, Deliberador TM, Cheah CW. A narrative review on means to promote oxygenation and angiogenesis in oral wound healing. Bioengineering (Basel) 2022; 9 (11) 636
• 10 Costa DA, Costa TP, Netto EC. et al. New perspectives on the conservative management of osteoradionecrosis of the mandible: a literature review. Head Neck 2016; 38 (11) 1708-1716
• 11 Risk of Bias 2 (RoB 2) tool. Accessed March 2, 2023 at: https://methods.cochrane.org/risk-bias-2
• 12 Bero L, Chartres N, Diong J. et al. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures. Syst Rev 2018; 7 (01) 242
• 13 Agency for Healthcare Research and Quality. Grading the Strength of a Body of Evidence when Comparing Medical Interventions. Accessed April 20, 2023 at: https://effectivehealthcare.ahrq.gov/products/methods-guidance-grading-strength/methods
• 14 Jenwitheesuk K, Mahakkanukrauh A, Punjaruk W. et al. Efficacy of adjunctive hyperbaric oxygen therapy in osteoradionecrosis. Biores Open Access 2018; 7 (01) 145-149
• 15 Vudiniabola S, Pirone C, Williamson J, Goss AN. Hyperbaric oxygen in the prevention of osteoradionecrosis of the jaws. Aust Dent J 1999; 44 (04) 243-247
• 16 Annane D, Depondt J, Aubert P. et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol 2004; 22 (24) 4893-4900
• 17 Shaw RJ, Butterworth CJ, Silcocks P. et al. HOPON (hyperbaric oxygen for the prevention of osteoradionecrosis): a randomized controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery. Int J Radiat Oncol Biol Phys 2019; 104 (03) 530-539
• 18 Gupta P, Sahni T, Jadhav GK, Manocha S, Aggarwal S, Verma S. A retrospective study of outcomes in subjects of head and neck cancer treated with hyperbaric oxygen therapy for radiation induced osteoradionecrosis of mandible at a tertiary care centre: an Indian experience. Indian J Otolaryngol Head Neck Surg 2013; 65 (Suppl. 01) 140-143
• 19 Forner LE, Dieleman FJ, Shaw RJ. et al. Hyperbaric oxygen treatment of mandibular osteoradionecrosis: combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1. Radiother Oncol 2022; 166: 137-144
• 20 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372 (71) n71
• 21 Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M. Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 2018; 69: 177-187
• 22 Devi S, Singh N. Dental care during and after radiotherapy in head and neck cancer. Natl J Maxillofac Surg 2014; 5 (02) 117-125
• 23 Shah J. Hyperbaric oxygen therapy. J Am Col Certif Wound Spec 2010; 2 (01) 9-13
• 24 Schultz GS, Chin GA, Moldawer L, Diegelmann RF. Principles of wound healing. In: Fitridge R, Thompson M. eds. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists. Adelaide, Australia: University of Adelaide Press; 2011
• 25 Sultan A, Hanna GJ, Margalit DN. et al. The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary guideline. Oncologist 2017; 22 (03) 343-350
• 26 Harding SA, Hodder SC, Courtney DJ, Bryson PJ. Impact of perioperative hyperbaric oxygen therapy on the quality of life of maxillofacial patients who undergo surgery in irradiated fields. Int J Oral Maxillofac Surg 2008; 37 (07) 617-624